A virtual dual-action program for patients across Texas, founded and run from Houston by two Board-Certified Nurse Practitioners. Compounded Tirzepatide acts on two metabolic pathways at once, GLP-1 and GIP, producing the strongest weight loss of any class of medication studied to date. Monthly video visits, dose titration, and medication delivered to your door.
Initial consultation, evaluation, and personalized plan included at no cost.
Tirzepatide is a dual-action medication that activates both GLP-1 and GIP receptors. Two hormones, two pathways, one combined effect on appetite and metabolism, more powerful than either alone.
Like Semaglutide, Tirzepatide slows gastric emptying and reduces appetite signals from the brain. Food stays in your stomach longer, you feel full faster, and the post-meal hunger spike is dramatically reduced.
The second pathway. GIP improves how your body processes fat, enhances insulin response after meals, and may quiet the food noise more powerfully than GLP-1 alone. This is what makes Tirzepatide different.
In head-to-head clinical trials, Tirzepatide produced more weight loss than Semaglutide in most patients. The dual-action approach is the reason. Side effects can also be more pronounced, especially during dose increases.
Tirzepatide is titrated up gradually to allow your body to adjust and minimize side effects. Most patients start at the lowest dose for 4 weeks, then increase as tolerated. Pricing reflects the dose level, with all NP visits and dose adjustments included.
Lowest dose. Body adjusts to the dual-action mechanism. Minimal side effects expected. Most patients stay here for one month before moving up.
Gradual increase. Hunger reduction becomes pronounced and food noise quiets. Most early weight loss occurs in this phase. Dose adjusted based on your response.
Full therapeutic dose for sustained, accelerated weight loss. Many patients reach their target dose here and remain for the rest of the program. Some require less.
Pricing includes the medication, all NP visits, dose adjustments, and ongoing clinical support. The initial consultation is always free, with no commitment to start the program. Lab work, if needed, is billed separately at our partner lab.
Like any medication that creates real change, Tirzepatide can produce side effects, especially during the first week of each dose increase. The most common are nausea, mild constipation, and lower energy, and most resolve within a week or two as your body adjusts. Because the dual-action mechanism is more powerful, side effects can feel slightly more pronounced than with Semaglutide for some patients. We screen carefully before starting, choose your titration pace based on how you’re feeling, and stay close throughout. If at any point the program isn’t right for you, we’ll say so and pause, no charge for unused medication.
The first video visit is free, with no obligation. Reach out to schedule a 45-minute consultation from wherever you are in Texas. We’ll talk through your goals, answer every question, and decide together whether Tirzepatide is the right next step.
Or call [Phone Number] · We answer personally
Tirzepatide is a dual-action medication that activates both GLP-1 and GIP receptors, two natural gut hormones involved in appetite regulation, blood sugar control, and metabolism. Compared to GLP-1-only medications like Semaglutide, Tirzepatide’s dual mechanism produces stronger appetite suppression and faster weight loss for most patients in clinical trials, though side effect rates are also somewhat higher. The medication doesn’t override your biology, it works with two pathways at once.
Clinical trials of branded Tirzepatide showed average weight loss of approximately 21 percent of starting body weight at the highest dose over 72 weeks, the largest sustained weight loss of any GLP-1 class medication studied to date. Real-world results vary widely based on starting weight, dose, nutrition, sleep, stress, and activity level. Most patients in our program lose 1.5 to 3 pounds per week during the active dose-titration phase. Weight loss typically slows as you approach your maintenance dose, which is normal and expected.
The active medication, Tirzepatide, is the same molecule as in branded products like Mounjaro and Zepbound. We use compounded Tirzepatide sourced from a licensed compounding pharmacy. Compounded versions are typically more affordable and currently more available than the branded products, which have had supply constraints. Compounded medications are not FDA-approved as finished products in the same way branded medications are; we are transparent about this so you can make an informed decision.
Our Tirzepatide pricing is tiered by dose, ranging from $349 to $449 per month. The lower doses (used in the early titration phase) are at the lower price point, and the higher therapeutic doses are at the upper end. Pricing includes the medication, all NP visits, and ongoing dose adjustments. The initial consultation is always free, with no obligation to start the program. The price difference vs Semaglutide reflects both the higher cost of compounded Tirzepatide and the larger doses involved.
There’s no universal right answer. Tirzepatide tends to produce more weight loss and is the right choice for patients with significant weight to lose or who want the most aggressive option available. Semaglutide is well-studied, less expensive, and may be the better starting point for patients new to GLP-1 therapy or with smaller weight loss goals. Some patients try Semaglutide first and switch to Tirzepatide if results plateau. We help you decide during the free first visit based on your goals, history, and budget.
Nausea, constipation, fatigue, and diarrhea are the most commonly reported side effects, particularly during the first week of each dose increase. These tend to be somewhat more pronounced with Tirzepatide than with Semaglutide due to the dual mechanism. For most patients, side effects are still mild and resolve within 1 to 2 weeks. Eating smaller, lower-fat meals and staying well-hydrated significantly reduces severity. We coach you through dose changes and adjust the titration schedule if side effects are excessive. Serious side effects are rare but include pancreatitis and gallbladder issues, which we screen for in advance.
There’s no fixed end date. Some patients use Tirzepatide for 9 to 18 months to reach a target weight, then taper off slowly while maintaining the lifestyle changes built during the program. Others stay on a maintenance dose long-term, similar to how patients use medications for blood pressure or cholesterol. Because Tirzepatide produces more weight loss, the time horizon may be shorter than Semaglutide for some patients. The right length depends on your goals, response, and how your body adjusts. We discuss this openly throughout the program.
If you stop the medication and return to your previous eating patterns, weight regain is common. The same is true of any weight-loss intervention. The patients who maintain their results long-term are those who use the program as a window to build sustainable habits around portion control, protein intake, sleep, and movement. We focus heavily on this throughout your monthly visits, because the medication is a tool, not a cure. The behavioral patterns built during the active weight-loss phase are what determine long-term success.
No. Our weight loss program is fully telehealth and serves patients across Texas. We’re founded in Houston and our Nurse Practitioners are licensed in Texas, so anyone with a Texas address can enroll. Video visits work from anywhere, and your medication ships discreetly to your door.
After your first video visit and approval to start, your compounded Tirzepatide ships directly from a licensed compounding pharmacy to your home address. The package includes the medication, syringes, alcohol swabs, and a sharps container for safe disposal. Shipments are temperature-controlled and tracked. You typically receive your first shipment within a week of your first visit.
The well-studied original GLP-1 medication. Steady, predictable weight loss for most patients. Lower dose tier and lower monthly cost. The first choice for most patients new to GLP-1 therapy.
A newer dual-action medication (GLP-1 plus GIP). Often produces faster and more substantial weight loss in clinical trials. Higher dose tier and higher monthly cost. Worth considering if Semaglutide alone isn’t enough.